Ginkgo Bioworks Holdings, Inc. SEC filings DNA
Ginkgo Bioworks Holdings, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Jun 14, 2023. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Oct 29, 2026 | Oct 29, 2026 |
| 4 | Insider transaction | Oct 21, 2026 | Oct 16, 2026 |
| 4 | Insider transaction | Oct 21, 2026 | Oct 16, 2026 |
| 4 | Insider transaction | Oct 21, 2026 | Oct 16, 2026 |
| 4 | Insider transaction | Oct 21, 2026 | Oct 16, 2026 |
| 144 | Notice of proposed sale | Oct 19, 2026 | — |
| 144 | Notice of proposed sale | Oct 19, 2026 | — |
| 144 | Notice of proposed sale | Oct 19, 2026 | — |
| 144 | Notice of proposed sale | Oct 19, 2026 | — |
| 144 | Notice of proposed sale | Oct 19, 2026 | — |
| 144 | Notice of proposed sale | Oct 19, 2026 | — |
| 4 | Insider transaction | Oct 7, 2026 | Oct 5, 2026 |
| 144 | Notice of proposed sale | Oct 5, 2026 | — |
| 144 | Notice of proposed sale | Sep 17, 2026 | — |
| 4 | Insider transaction | Sep 16, 2026 | Sep 15, 2026 |
| 144 | Notice of proposed sale | Sep 15, 2026 | — |
| 4 | Insider transaction | Aug 25, 2026 | Aug 21, 2026 |
| 144 | Notice of proposed sale | Aug 24, 2026 | — |
| 144 | Notice of proposed sale | Aug 17, 2026 | — |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 4 | Insider transaction | Jul 30, 2026 | Jul 28, 2026 |
| 4 | Insider transaction | Jul 30, 2026 | Jul 28, 2026 |
| 4 | Insider transaction | Jul 30, 2026 | Jul 28, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 30, 2026 | Jul 30, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 30, 2026 | — |
| 4 | Insider transaction | Jul 20, 2026 | Jul 16, 2026 |
| 144 | Notice of proposed sale | Jul 17, 2026 | — |
| 4 | Insider transaction | Jun 15, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2026 | Jun 11, 2026 |
| 144 | Notice of proposed sale | Jun 10, 2026 | — |
| 4 | Insider transaction | May 26, 2026 | May 21, 2026 |
| 144 | Notice of proposed sale | May 22, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 144 | Notice of proposed sale | May 13, 2026 | — |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| DEF 14A | Proxy statement | Apr 29, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Apr 20, 2026 | Apr 16, 2026 |
| 144 | Notice of proposed sale | Apr 17, 2026 | — |
| 144 | Notice of proposed sale | Apr 15, 2026 | — |
| 4 | Insider transaction | Apr 14, 2026 | Apr 10, 2026 |
| 4 | Insider transaction | Apr 13, 2026 | Apr 9, 2026 |
| 4 | Insider transaction | Apr 13, 2026 | Apr 9, 2026 |
| 144 | Notice of proposed sale | Apr 13, 2026 | — |
| 144 | Notice of proposed sale | Apr 13, 2026 | — |
| 4 | Insider transaction | Apr 10, 2026 | Apr 7, 2026 |
| 4 | Insider transaction | Apr 10, 2026 | Apr 7, 2026 |
| 4 | Insider transaction | Apr 10, 2026 | Apr 7, 2026 |
| 144 | Notice of proposed sale | Apr 10, 2026 | — |
| 144 | Notice of proposed sale | Apr 9, 2026 | — |
| 144 | Notice of proposed sale | Apr 9, 2026 | — |
| 144 | Notice of proposed sale | Apr 8, 2026 | — |
| 144 | Notice of proposed sale | Apr 8, 2026 | — |
| 8-K |
Current report
Acquisition or sale of assets
|
Apr 7, 2026 | Apr 3, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 26, 2026 | — |
| 4 | Insider transaction | Mar 18, 2026 | Mar 13, 2026 |
| 144 | Notice of proposed sale | Mar 16, 2026 | — |
| 144 | Notice of proposed sale | Mar 11, 2026 | — |
| 8-K |
Current report
Material agreement
|
Feb 27, 2026 | Feb 26, 2026 |
| S-8 | Employee stock plan registration | Feb 26, 2026 | — |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 5, 2026 | — |
| 144 | Notice of proposed sale | Feb 4, 2026 | — |
| 4 | Insider transaction | Jan 22, 2026 | Jan 16, 2026 |
| 144 | Notice of proposed sale | Jan 20, 2026 | — |
| 144 | Notice of proposed sale | Jan 7, 2026 | — |
| 8-K |
Current report
Officer or director change, Other events
|
Dec 23, 2025 | Dec 18, 2025 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 12, 2025 |
| 144 | Notice of proposed sale | Dec 15, 2025 | — |
| 144 | Notice of proposed sale | Dec 10, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 144 | Notice of proposed sale | Nov 12, 2025 | — |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 4 | Insider transaction | Oct 21, 2025 | Oct 16, 2025 |
| 144 | Notice of proposed sale | Oct 21, 2025 | — |
| 144 | Notice of proposed sale | Oct 21, 2025 | — |
| 144 | Notice of proposed sale | Oct 8, 2025 | — |
| 4 | Insider transaction | Oct 3, 2025 | Oct 1, 2025 |
| 4 | Insider transaction | Sep 10, 2025 | Sep 8, 2025 |
| 144 | Notice of proposed sale | Sep 10, 2025 | — |
| 144 | Notice of proposed sale | Sep 9, 2025 | — |
| 144 | Notice of proposed sale | Sep 8, 2025 | — |
| 8-K |
Current report
Material agreement
|
Sep 4, 2025 | Sep 4, 2025 |
| 424B5 | Prospectus supplement | Sep 4, 2025 | — |
| 8-K |
Current report
Other events
|
Aug 29, 2025 | Aug 29, 2025 |
| 4 | Insider transaction | Aug 26, 2025 | Aug 21, 2025 |
| EFFECT | Filing | Aug 14, 2025 | — |
| CORRESP | Letter to the SEC | Aug 12, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 12, 2025 | — |
| S-3 | Shelf registration | Aug 7, 2025 | — |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 144 | Notice of proposed sale | Aug 6, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 29, 2025 | — |
| 4 | Insider transaction | Jul 21, 2025 | Jul 16, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 17, 2025 | — |
| 144 | Notice of proposed sale | Jul 17, 2025 | — |
| 144 | Notice of proposed sale | Jul 9, 2025 | — |
| 144 | Notice of proposed sale | Jun 23, 2025 | — |
| 144 | Notice of proposed sale | Jun 20, 2025 | — |
| 144 | Notice of proposed sale | Jun 18, 2025 | — |
| 144 | Notice of proposed sale | Jun 17, 2025 | — |
| 144 | Notice of proposed sale | Jun 16, 2025 | — |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2025 | Jun 12, 2025 |
| 144 | Notice of proposed sale | Jun 13, 2025 | — |
| 144 | Notice of proposed sale | Jun 12, 2025 | — |
| 144 | Notice of proposed sale | Jun 11, 2025 | — |
| 144 | Notice of proposed sale | Jun 10, 2025 | — |
| 144 | Notice of proposed sale | Jun 9, 2025 | — |
| 144 | Notice of proposed sale | Jun 6, 2025 | — |
| 144 | Notice of proposed sale | Jun 5, 2025 | — |
| 144 | Notice of proposed sale | Jun 4, 2025 | — |
| 144 | Notice of proposed sale | Jun 3, 2025 | — |
| 144 | Notice of proposed sale | Jun 2, 2025 | — |
| 144 | Notice of proposed sale | May 30, 2025 | — |
| 144 | Notice of proposed sale | May 29, 2025 | — |
| 144 | Notice of proposed sale | May 28, 2025 | — |
| 144 | Notice of proposed sale | May 27, 2025 | — |
| 144 | Notice of proposed sale | May 23, 2025 | — |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 144 | Notice of proposed sale | May 22, 2025 | — |
| 144 | Notice of proposed sale | May 21, 2025 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 21, 2025 | May 19, 2025 |
| 144 | Notice of proposed sale | May 21, 2025 | — |
| 144 | Notice of proposed sale | May 20, 2025 | — |
| 144 | Notice of proposed sale | May 19, 2025 | — |
| 144 | Notice of proposed sale | May 16, 2025 | — |
| 144 | Notice of proposed sale | May 15, 2025 | — |
| 144 | Notice of proposed sale | May 14, 2025 | — |
| 144 | Notice of proposed sale | May 13, 2025 | — |
| 144 | Notice of proposed sale | May 12, 2025 | — |
| 144 | Notice of proposed sale | May 9, 2025 | — |
| 144 | Notice of proposed sale | May 8, 2025 | — |
| 144 | Notice of proposed sale | May 7, 2025 | — |
| 10-Q | Quarterly report | May 6, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 6, 2025 | May 6, 2025 |
| 144 | Notice of proposed sale | May 6, 2025 | — |
| 144 | Notice of proposed sale | May 5, 2025 | — |
| 144 | Notice of proposed sale | May 2, 2025 | — |
| 144 | Notice of proposed sale | May 1, 2025 | — |
| 144 | Notice of proposed sale | Apr 30, 2025 | — |
| ARS | Annual report to shareholders | Apr 29, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Jun 12, 2025 |
| 144 | Notice of proposed sale | Apr 29, 2025 | — |
| 144 | Notice of proposed sale | Apr 28, 2025 | — |
| 144 | Notice of proposed sale | Apr 25, 2025 | — |
| 144 | Notice of proposed sale | Apr 24, 2025 | — |
| 4 | Insider transaction | Apr 23, 2025 | Apr 17, 2025 |
| 4 | Insider transaction | Apr 23, 2025 | Apr 17, 2025 |
| 144 | Notice of proposed sale | Apr 23, 2025 | — |
| 144 | Notice of proposed sale | Apr 22, 2025 | — |
| 144 | Notice of proposed sale | Apr 21, 2025 | — |
| 144 | Notice of proposed sale | Apr 21, 2025 | — |
| 144 | Notice of proposed sale | Apr 17, 2025 | — |
| 144 | Notice of proposed sale | Apr 16, 2025 | — |
| 144 | Notice of proposed sale | Apr 15, 2025 | — |
| 144 | Notice of proposed sale | Apr 14, 2025 | — |
| 144 | Notice of proposed sale | Apr 11, 2025 | — |
| 144 | Notice of proposed sale | Apr 10, 2025 | — |
| 144 | Notice of proposed sale | Apr 9, 2025 | — |
| 144 | Notice of proposed sale | Apr 8, 2025 | — |
| 144 | Notice of proposed sale | Apr 7, 2025 | — |
| 144 | Notice of proposed sale | Apr 4, 2025 | — |
| 144 | Notice of proposed sale | Apr 3, 2025 | — |
| 144 | Notice of proposed sale | Apr 2, 2025 | — |
| 144 | Notice of proposed sale | Apr 1, 2025 | — |
| 144 | Notice of proposed sale | Mar 31, 2025 | — |
| 144 | Notice of proposed sale | Mar 28, 2025 | — |
| 144 | Notice of proposed sale | Mar 27, 2025 | — |
| 144 | Notice of proposed sale | Mar 26, 2025 | — |
| 144 | Notice of proposed sale | Mar 25, 2025 | — |
| 144 | Notice of proposed sale | Mar 24, 2025 | — |
| 144 | Notice of proposed sale | Mar 21, 2025 | — |
| 144 | Notice of proposed sale | Mar 20, 2025 | — |
| 144 | Notice of proposed sale | Mar 19, 2025 | — |
| 144 | Notice of proposed sale | Mar 18, 2025 | — |
| 4 | Insider transaction | Mar 17, 2025 | Mar 13, 2025 |
| 144 | Notice of proposed sale | Mar 17, 2025 | — |
| 144 | Notice of proposed sale | Mar 14, 2025 | — |
| 144 | Notice of proposed sale | Mar 13, 2025 | — |
| 144 | Notice of proposed sale | Mar 12, 2025 | — |
| 144 | Notice of proposed sale | Mar 11, 2025 | — |
| 4 | Insider transaction | Mar 10, 2025 | Mar 6, 2025 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- DNA (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1830214
- Former names
- Soaring Eagle Acquisition Corp. (until Sep 17, 2021); Spinning Eagle Acquisition Corp. (until Jan 4, 2021)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.